Can the pharmaceutical industry reduce attrition rates? View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2004-08

AUTHORS

Ismail Kola, John Landis

ABSTRACT

The pharmaceutical industry faces considerable challenges, both politically and fiscally. Politically, governments around the world are trying to contain costs and, as health care budgets constitute a very significant part of governmental spending, these costs are the subject of intense scrutiny. In the United States, drug costs are also the subject of intense political discourse. This article deals with the fiscal pressures that face the industry from the perspective of R&D. What impinges on productivity? How can we improve current reduced R&D productivity? More... »

PAGES

711-716

References to SciGraph publications

  • 2004-02. 2003 approvals: a year of innovation and upward trends in NATURE REVIEWS DRUG DISCOVERY
  • 2003-08. Oncology's trials in NATURE REVIEWS DRUG DISCOVERY
  • 2002-08. Value of novelty? in NATURE REVIEWS DRUG DISCOVERY
  • Journal

    TITLE

    Nature Reviews Drug Discovery

    ISSUE

    8

    VOLUME

    3

    Related Patents

  • Analogs Of Dehydrophenylahistins And Their Therapeutic Use
  • Compounds
  • Use Of Inhibitors Of Bruton's Tyrosine Kinase (Btk)
  • Analogs Of Dehydrophenylahistins And Their Therapeutic Use
  • Metastin Derivatives And Use Thereof
  • Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors
  • Combinations For The Treatment Of Diseases Involving Cell Proliferation
  • Inhibitors Of Bruton's Tyrosine Kinase
  • Inhibitors Of Bruton's Tyrosine Kinase
  • Niclosamide And Its Derivatives For Use In The Treatment Of Solid Tumors
  • Phospholipase C Gamma 2 And Resistance Associated Mutations
  • Dehydrophenylahistins And Analogs Thereof And The Synthesis Of Dehydrophenylahistins And Analogs Thereof
  • Methods For The Treatment Of Her2 Amplified Cancer
  • Use Of Inhibitors Of Bruton's Tyrosine Kinase (Btk)
  • Use Of Inhibitors Of Bruton's Tyrosine Kinase (Btk)
  • Use Of Inhibitors Of Bruton's Tyrosine Kinase (Btk)
  • Niclosamide And Its Derivatives For Use In The Treatment Of Solid Tumors
  • Metastin Derivatives And Use Thereof
  • Method For Treatment Of Advanced Solid Tumors
  • Method For Treating Acute Myeloid Leukemia
  • Method Of Treating A Brain Tumor
  • Pyrrolopyrimidine Compounds As Kinase Inhibitors
  • Niclosamide And Its Derivatives For Use In The Treatment Of Solid Tumors
  • Analogs Of Dehydrophenylahistins And Their Therapeutic Use
  • Treatment Of Myelodysplastic Syndrome
  • Metastin Derivatives And Use Thereof
  • Pyrazolo[3,4-D]Pyrimidine And Pyrazolo[2,3-D]Pyrimidine Compounds As Kinase Inhibitors
  • Combination Treatment Of Acute Myeloid Leukemia And Myelodysplastic Syndrome
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nrd1470

    DOI

    http://dx.doi.org/10.1038/nrd1470

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1041019353

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/15286737


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1606", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Political Science", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/16", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Studies in Human Society", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Clinical Trials as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Approval", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Industry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pharmacokinetics", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "name": [
                "Basic Research at Merck Research Labs, 126 East Lincoln Avenue, Rahway, New Jersey 07075, USA. ismail_kola@merck.com"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kola", 
            "givenName": "Ismail", 
            "id": "sg:person.0663573463.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663573463.92"
            ], 
            "type": "Person"
          }, 
          {
            "familyName": "Landis", 
            "givenName": "John", 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrd884", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003573245", 
              "https://doi.org/10.1038/nrd884"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd884", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003573245", 
              "https://doi.org/10.1038/nrd884"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1158", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006461295", 
              "https://doi.org/10.1038/nrd1158"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1158", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006461295", 
              "https://doi.org/10.1038/nrd1158"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1327", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010619040", 
              "https://doi.org/10.1038/nrd1327"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1327", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010619040", 
              "https://doi.org/10.1038/nrd1327"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0167-6296(02)00126-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034082462"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0167-6296(02)00126-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034082462"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1359/jbmr.1999.14.10.1654", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044423469"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1357-4310(99)01563-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050384326"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/hmg/10.12.1317", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053363177"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2004-08", 
        "datePublishedReg": "2004-08-01", 
        "description": "The pharmaceutical industry faces considerable challenges, both politically and fiscally. Politically, governments around the world are trying to contain costs and, as health care budgets constitute a very significant part of governmental spending, these costs are the subject of intense scrutiny. In the United States, drug costs are also the subject of intense political discourse. This article deals with the fiscal pressures that face the industry from the perspective of R&D. What impinges on productivity? How can we improve current reduced R&D productivity?", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/nrd1470", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1327423", 
            "issn": [
              "1474-1776", 
              "1474-1784"
            ], 
            "name": "Nature Reviews Drug Discovery", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "8", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "3"
          }
        ], 
        "name": "Can the pharmaceutical industry reduce attrition rates?", 
        "pagination": "711-716", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "c367358a2cd0629e0ab31f36b383b98dab1a595e31a6ffa5f519862795964d3f"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "15286737"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "101124171"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nrd1470"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1041019353"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nrd1470", 
          "https://app.dimensions.ai/details/publication/pub.1041019353"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T11:53", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29200_00000002.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://www.nature.com/nrd/journal/v3/n8/full/nrd1470.html"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nrd1470'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nrd1470'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nrd1470'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nrd1470'


     

    This table displays all metadata directly associated to this object as RDF triples.

    121 TRIPLES      21 PREDICATES      42 URIs      27 LITERALS      15 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nrd1470 schema:about N186c7dc37c78489a84ce55fe6efd3c59
    2 N32db3fc5af1d48eb94dcb497cb36ef45
    3 N3a39fd71a02f4b1fbafdaccb5be744d3
    4 N48c2daeb60484f3cb00fecf49bee75b1
    5 Nefbe8e3706674b1983c5c50d6301c1be
    6 Nff0fc3777fc84abc92e98bfff8e19ce3
    7 anzsrc-for:16
    8 anzsrc-for:1606
    9 schema:author N6c68030e593f49139e5cc9c51e49723f
    10 schema:citation sg:pub.10.1038/nrd1158
    11 sg:pub.10.1038/nrd1327
    12 sg:pub.10.1038/nrd884
    13 https://doi.org/10.1016/s0167-6296(02)00126-1
    14 https://doi.org/10.1016/s1357-4310(99)01563-4
    15 https://doi.org/10.1093/hmg/10.12.1317
    16 https://doi.org/10.1359/jbmr.1999.14.10.1654
    17 schema:datePublished 2004-08
    18 schema:datePublishedReg 2004-08-01
    19 schema:description The pharmaceutical industry faces considerable challenges, both politically and fiscally. Politically, governments around the world are trying to contain costs and, as health care budgets constitute a very significant part of governmental spending, these costs are the subject of intense scrutiny. In the United States, drug costs are also the subject of intense political discourse. This article deals with the fiscal pressures that face the industry from the perspective of R&D. What impinges on productivity? How can we improve current reduced R&D productivity?
    20 schema:genre research_article
    21 schema:inLanguage en
    22 schema:isAccessibleForFree true
    23 schema:isPartOf N8d8e104480fd4787bba9fdb25a93a75d
    24 Neb986f98e68d477ea434caf727a9f104
    25 sg:journal.1327423
    26 schema:name Can the pharmaceutical industry reduce attrition rates?
    27 schema:pagination 711-716
    28 schema:productId N13b0dfa96e63459a8d57a9ad565c89d9
    29 N3dc71f3808354c428a8b678faaf6ba99
    30 Nbbce05b00480425d92e8275063b5c347
    31 Nc0ec78b2ecb747ad97f5c815b7725a41
    32 Nd5accf0ab0cf44588ec9499accf9fa45
    33 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041019353
    34 https://doi.org/10.1038/nrd1470
    35 schema:sdDatePublished 2019-04-11T11:53
    36 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    37 schema:sdPublisher N8fee9111d64a4f8fb6e606746da32f20
    38 schema:url http://www.nature.com/nrd/journal/v3/n8/full/nrd1470.html
    39 sgo:license sg:explorer/license/
    40 sgo:sdDataset articles
    41 rdf:type schema:ScholarlyArticle
    42 N13b0dfa96e63459a8d57a9ad565c89d9 schema:name pubmed_id
    43 schema:value 15286737
    44 rdf:type schema:PropertyValue
    45 N186c7dc37c78489a84ce55fe6efd3c59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    46 schema:name Clinical Trials as Topic
    47 rdf:type schema:DefinedTerm
    48 N32db3fc5af1d48eb94dcb497cb36ef45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    49 schema:name Humans
    50 rdf:type schema:DefinedTerm
    51 N3a39fd71a02f4b1fbafdaccb5be744d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    52 schema:name Drug Approval
    53 rdf:type schema:DefinedTerm
    54 N3dc71f3808354c428a8b678faaf6ba99 schema:name doi
    55 schema:value 10.1038/nrd1470
    56 rdf:type schema:PropertyValue
    57 N48c2daeb60484f3cb00fecf49bee75b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    58 schema:name Drug Industry
    59 rdf:type schema:DefinedTerm
    60 N6c68030e593f49139e5cc9c51e49723f rdf:first sg:person.0663573463.92
    61 rdf:rest N89bb5a936153437aa42451b6e6ee195f
    62 N89bb5a936153437aa42451b6e6ee195f rdf:first Nfc14dac167384f8dafae3c02a3278fad
    63 rdf:rest rdf:nil
    64 N8d8e104480fd4787bba9fdb25a93a75d schema:volumeNumber 3
    65 rdf:type schema:PublicationVolume
    66 N8fee9111d64a4f8fb6e606746da32f20 schema:name Springer Nature - SN SciGraph project
    67 rdf:type schema:Organization
    68 Nbbce05b00480425d92e8275063b5c347 schema:name dimensions_id
    69 schema:value pub.1041019353
    70 rdf:type schema:PropertyValue
    71 Nc0ec78b2ecb747ad97f5c815b7725a41 schema:name readcube_id
    72 schema:value c367358a2cd0629e0ab31f36b383b98dab1a595e31a6ffa5f519862795964d3f
    73 rdf:type schema:PropertyValue
    74 Nd502695fb42f4512845881f28ddb3269 schema:name Basic Research at Merck Research Labs, 126 East Lincoln Avenue, Rahway, New Jersey 07075, USA. ismail_kola@merck.com
    75 rdf:type schema:Organization
    76 Nd5accf0ab0cf44588ec9499accf9fa45 schema:name nlm_unique_id
    77 schema:value 101124171
    78 rdf:type schema:PropertyValue
    79 Neb986f98e68d477ea434caf727a9f104 schema:issueNumber 8
    80 rdf:type schema:PublicationIssue
    81 Nefbe8e3706674b1983c5c50d6301c1be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    82 schema:name Drug Design
    83 rdf:type schema:DefinedTerm
    84 Nfc14dac167384f8dafae3c02a3278fad schema:familyName Landis
    85 schema:givenName John
    86 rdf:type schema:Person
    87 Nff0fc3777fc84abc92e98bfff8e19ce3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name Pharmacokinetics
    89 rdf:type schema:DefinedTerm
    90 anzsrc-for:16 schema:inDefinedTermSet anzsrc-for:
    91 schema:name Studies in Human Society
    92 rdf:type schema:DefinedTerm
    93 anzsrc-for:1606 schema:inDefinedTermSet anzsrc-for:
    94 schema:name Political Science
    95 rdf:type schema:DefinedTerm
    96 sg:journal.1327423 schema:issn 1474-1776
    97 1474-1784
    98 schema:name Nature Reviews Drug Discovery
    99 rdf:type schema:Periodical
    100 sg:person.0663573463.92 schema:affiliation Nd502695fb42f4512845881f28ddb3269
    101 schema:familyName Kola
    102 schema:givenName Ismail
    103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663573463.92
    104 rdf:type schema:Person
    105 sg:pub.10.1038/nrd1158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006461295
    106 https://doi.org/10.1038/nrd1158
    107 rdf:type schema:CreativeWork
    108 sg:pub.10.1038/nrd1327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010619040
    109 https://doi.org/10.1038/nrd1327
    110 rdf:type schema:CreativeWork
    111 sg:pub.10.1038/nrd884 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003573245
    112 https://doi.org/10.1038/nrd884
    113 rdf:type schema:CreativeWork
    114 https://doi.org/10.1016/s0167-6296(02)00126-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034082462
    115 rdf:type schema:CreativeWork
    116 https://doi.org/10.1016/s1357-4310(99)01563-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050384326
    117 rdf:type schema:CreativeWork
    118 https://doi.org/10.1093/hmg/10.12.1317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053363177
    119 rdf:type schema:CreativeWork
    120 https://doi.org/10.1359/jbmr.1999.14.10.1654 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044423469
    121 rdf:type schema:CreativeWork
     




    Preview window. Press ESC to close (or click here)


    ...